Colospan
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Atir Yeda St, Kfar Saba, Central Dist...Phone Number
+972 97672518Website
www.colospan.comRevenue
<$5 MillionIndustry
About Colospan
Colospan Org Chart
Is Colospan your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Colospan had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Colospan
Funding: Get notified immidiatlly once Colospan has new funding data
Check if Colospan has recently received funding, and reach out quickly before it becomes old news!
Check out if Colospan is spiking on competitors!
Earning: See what the market has to say on Colospan recently announced quarterly report
Product Launch: Get notified when Colospan launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Colospan, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Colospan as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Colospan is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Colospan is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Colospan.
Colospan Tech Stack
A closer look at the technologies used by Colospan
Colospan News & Media
Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition
Colospan Ltd. ("Colospan") provides Galmed Pharmaceuticals Ltd. ("Galmed") (NASDAQ: GLMD) with a commercially ready product in the EU/Israel (CE marked under MDR) with a dedicated OPS code to accelerate reimbursement in Germany Strategic and Financial Highlights Restructured Anti-Dilutive...Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
Transaction will add FDA Breakthrough Device-Designated technology with active U.S. pivotal IDE trial, positioning Galmed to address one of colorectal surgery's most serious unmet needs. Colospan's CG-100 Intraluminal Bypass Device, is CE marked under EU's Medical Device Regulation...Colospan Receives FDA Breakthrough Device Designation for Its Intraluminal Bypass Device
CAMBRIDGE, MA, UNITED STATES, August 13, 2024 /EINPresswire.com/ -- Colospan, which develops novel solutions for colorectal surgery, announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Device Designation to …Colospan receives €8.2 million from the European Innovation Council for its novel colorectal surgery device
CAMBRIDGE, MA, UNITED STATES, December 20, 2021 /EINPresswire.com/ -- Colospan, which develops novel solutions for colorectal surgery, announced today that it has been awarded €8.2 million ($9.3 million) from the European Innovation Council (EIC) as part …
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Colospan
Colospan is a medical technology company focused on transforming colorectal surgery through its innovative product, CG-100, which serves as a minimally invasive alternative to diverting stomas. The device aims to reduce complications associated with anastomotic leaks, thereby improving clinical outcomes and lowering healthcare costs. Targeting pati... Read More